Stimulation of suicidal erythrocyte death by sulforaphane

Basic and Clinical Pharmacology and Toxicology

Volumn 116, Issue 3, 2015, Pages 229-235

  Alzoubi, Kousi ^a   Calabrò, Salvatrice ^a,b   Faggio, Caterina ^b   Lang, Florian ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b UNIVERSITY OF MESSINA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; CERAMIDE; FLUO 3; LIPOCORTIN 5; PHOSPHATIDYLSERINE; SULFORAPHANE; ANTINEOPLASTIC AGENT; ISOTHIOCYANIC ACID DERIVATIVE; SULFORAFAN;

APOPTOSIS; ARTICLE; CALCIUM TRANSPORT; CELL VOLUME; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CYTOSOL; DRUG MECHANISM; ERYTHROCYTE MEMBRANE; EXTRACELLULAR CALCIUM; FLOW CYTOMETRY; FLUORESCENCE; GENE EXPRESSION; HUMAN; HUMAN CELL; MEMBRANE DEPOLARIZATION; PRIORITY JOURNAL; STIMULATION; SUICIDAL ERYTHROCYTE DEATH; CELL DEATH; CELL SIZE; DOSE RESPONSE; DRUG EFFECTS; ERYTHROCYTE; METABOLISM;

ANNEXIN A5; ANTICARCINOGENIC AGENTS; APOPTOSIS; CALCIUM; CELL DEATH; CELL SIZE; CERAMIDES; DOSE-RESPONSE RELATIONSHIP, DRUG; ERYTHROCYTES; HUMANS; ISOTHIOCYANATES; PHOSPHATIDYLSERINES;

EID: 84922752468     PISSN: 17427835     EISSN: 17427843     Source Type: Journal    
DOI: 10.1111/bcpt.12309     Document Type: Article

References (104)

1. Lenzi M, Fimognari C, Hrelia P. Sulforaphane as a promising molecule for fighting cancer. Cancer Treat Res 2014;159:207-23.
2. Juge N, Mithen RF, Traka M. Molecular basis for chemoprevention by sulforaphane: a comprehensive review. Cell Mol Life Sci 2007;64:1105-27.
3. Fimognari C, Hrelia P. Sulforaphane as a promising molecule for fighting cancer. Mutat Res 2007;635:90-104.
4. Cheung KL, Kong AN. Molecular targets of dietary phenethyl isothiocyanate and sulforaphane for cancer chemoprevention. AAPS J 2010;12:87-97.
5. Clarke JD, Dashwood RH, Ho E. Multi-targeted prevention of cancer by sulforaphane. Cancer Lett 2008;269:291-304.
6. Gamet-Payrastre L. Signaling pathways and intracellular targets of sulforaphane mediating cell cycle arrest and apoptosis. Curr Cancer Drug Targets 2006;6:135-45.
7. Gills JJ, Jeffery EH, Matusheski NV, Moon RC, Lantvit DD, Pezzuto JM. Sulforaphane prevents mouse skin tumorigenesis during the stage of promotion. Cancer Lett 2006;236:72-9.
8. Negrette-Guzman M, Huerta-Yepez S, Tapia E, Pedraza-Chaverri J. Modulation of mitochondrial functions by the indirect antioxidant sulforaphane: a seemingly contradictory dual role and an integrative hypothesis. Free Radic Biol Med 2013;65:1078-89.
9. Myzak MC, Dashwood RH. Histone deacetylases as targets for dietary cancer preventive agents: lessons learned with butyrate, diallyl disulfide, and sulforaphane. Curr Drug Targets 2006;7:443-52.
10. Nian H, Delage B, Ho E, Dashwood RH. Modulation of histone deacetylase activity by dietary isothiocyanates and allyl sulfides: studies with sulforaphane and garlic organosulfur compounds. Environ Mol Mutagen 2009;50:213-21.
11. Lang E, Qadri SM, Lang F. Killing me softly - suicidal erythrocyte death. Int J Biochem Cell Biol 2012;44:1236-43.
12. Lang PA, Kaiser S, Myssina S, Wieder T, Lang F, Huber SM. Role of Ca2 + -activated K+ channels in human erythrocyte apoptosis. Am J Physiol Cell Physiol 2003;285:C1553-60.
13. Abed M, Towhid ST, Mia S, Pakladok T, Alesutan I, Borst O et al. Sphingomyelinase-induced adhesion of eryptotic erythrocytes to endothelial cells. Am J Physiol Cell Physiol 2012;303:C991-9.
14. Bhavsar SK, Bobbala D, Xuan NT, Foller M, Lang F. Stimulation of suicidal erythrocyte death by alpha-lipoic acid. Cell Physiol Biochem 2010;26:859-68.
15. Foller M, Feil S, Ghoreschi K, Koka S, Gerling A, Thunemann M et al. Anemia and splenomegaly in cGKI-deficient mice. Proc Natl Acad Sci USA 2008;105:6771-6.
16. Foller M, Mahmud H, Gu S, Wang K, Floride E, Kucherenko Y et al. Participation of leukotriene C(4) in the regulation of suicidal erythrocyte death. J Physiol Pharmacol 2009;60:135-43.
17. Lau IP, Chen H, Wang J, Ong HC, Leung KC, Ho HP et al. In vitro effect of CTAB- and PEG-coated gold nanorods on the induction of eryptosis/erythroptosis in human erythrocytes. Nanotoxicology 2012;6:847-56.
18. Maellaro E, Leoncini S, Moretti D, Del Bello B, Tanganelli I, De Felice C et al. Erythrocyte caspase-3 activation and oxidative imbalance in erythrocytes and in plasma of type 2 diabetic patients. Acta Diabetol 2013;50:489-95.
19. Foller M, Sopjani M, Koka S, Gu S, Mahmud H, Wang K et al. Regulation of erythrocyte survival by AMP-activated protein kinase. FASEB J 2009;23:1072-80.
20. Kucherenko Y, Zelenak C, Eberhard M, Qadri SM, Lang F. Effect of casein kinase 1alpha activator pyrvinium pamoate on erythrocyte ion channels. Cell Physiol Biochem 2012;30:407-17.
21. Zelenak C, Eberhard M, Jilani K, Qadri SM, Macek B, Lang F. Protein kinase CK1alpha regulates erythrocyte survival. Cell Physiol Biochem 2012;29:171-80.
22. Bhavsar SK, Gu S, Bobbala D, Lang F. Janus kinase 3 is expressed in erythrocytes, phosphorylated upon energy depletion and involved in the regulation of suicidal erythrocyte death. Cell Physiol Biochem 2011;27:547-56.
23. Klarl BA, Lang PA, Kempe DS, Niemoeller OM, Akel A, Sobiesiak M et al. Protein kinase C mediates erythrocyte "programmed cell death" following glucose depletion. Am J Physiol Cell Physiol 2006;290:C244-53.
24. Gatidis S, Zelenak C, Fajol A, Lang E, Jilani K, Michael D et al. p38 MAPK activation and function following osmotic shock of erythrocytes. Cell Physiol Biochem 2011;28:1279-86.
25. Zelenak C, Foller M, Velic A, Krug K, Qadri SM, Viollet B et al. Proteome analysis of erythrocytes lacking AMP-activated protein kinase reveals a role of PAK2 kinase in eryptosis. J Proteome Res 2011;10:1690-7.
26. Lupescu A, Jilani K, Zelenak C, Zbidah M, Qadri SM, Lang F. Hexavalent chromium-induced erythrocyte membrane phospholipid asymmetry. Biometals 2012;25:309-18.
27. Shaik N, Lupescu A, Lang F. Sunitinib-sensitive suicidal erythrocyte death. Cell Physiol Biochem 2012;30:512-22.
28. Abed M, Towhid ST, Shaik N, Lang F. Stimulation of suicidal death of erythrocytes by rifampicin. Toxicology 2012;302:123-8.
29. Bottger E, Multhoff G, Kun JF, Esen M. Plasmodium falciparum-infected erythrocytes induce granzyme B by NK cells through expression of host-Hsp70. PLoS ONE 2012;7:e33774.
30. Firat U, Kaya S, Cim A, Buyukbayram H, Gokalp O, Dal MS et al. Increased caspase-3 immunoreactivity of erythrocytes in STZ diabetic rats. Exp Diabetes Res 2012;2012:316384.
31. Ganesan S, Chaurasiya ND, Sahu R, Walker LA, Tekwani BL. Understanding the mechanisms for metabolism-linked hemolytic toxicity of primaquine against glucose 6-phosphate dehydrogenase deficient human erythrocytes: evaluation of eryptotic pathway. Toxicology 2012;294:54-60.
32. Gao M, Cheung KL, Lau IP, Yu WS, Fung KP, Yu B et al. Polyphyllin D induces apoptosis in human erythrocytes through Ca(2)(+) rise and membrane permeabilization. Arch Toxicol 2012;86:741-52.
33. Ghashghaeinia M, Cluitmans JC, Akel A, Dreischer P, Toulany M, Koberle M et al. The impact of erythrocyte age on eryptosis. Br J Haematol 2012;157:606-14.
34. Jilani K, Lupescu A, Zbidah M, Abed M, Shaik N, Lang F. Enhanced Apoptotic Death of Erythrocytes Induced by the Mycotoxin Ochratoxin A. Kidney Blood Press Res 2012;36:107-18.
35. Jilani K, Qadri SM, Lang F. Geldanamycin-induced phosphatidylserine translocation in the erythrocyte membrane. Cell Physiol Biochem 2013;32:1600-9.
36. Kucherenko YV, Lang F. Inhibitory effect of furosemide on non-selective voltage-independent cation channels in human erythrocytes. Cell Physiol Biochem 2012;30:863-75.
37. Lupescu A, Jilani K, Zbidah M, Lang E, Lang F. Enhanced ca(2 + ) entry, ceramide formation, and apoptotic death of erythrocytes triggered by plumbagin. J Nat Prod 2012;75:1956-61.
38. Lupescu A, Jilani K, Zbidah M, Lang F. Induction of apoptotic erythrocyte death by rotenone. Toxicology 2012;300:132-7.
39. Polak-Jonkisz D, Purzyc L. Ca influx versus efflux during eryptosis in uremic erythrocytes. Blood Purif 2012;34:209-10.
40. Qian EW, Ge DT, Kong SK. Salidroside protects human erythrocytes against hydrogen peroxide-induced apoptosis. J Nat Prod 2012;75:531-7.
41. Shaik N, Zbidah M, Lang F. Inhibition of Ca(2 + ) entry and suicidal erythrocyte death by naringin. Cell Physiol Biochem 2012;30:678-86.
42. Vota DM, Maltaneri RE, Wenker SD, Nesse AB, Vittori DC. Differential erythropoietin action upon cells induced to eryptosis by different agents. Cell Biochem Biophys 2013;65:145-57.
43. Weiss E, Cytlak UM, Rees DC, Osei A, Gibson JS. Deoxygenation-induced and Ca(2 + ) dependent phosphatidylserine externalisation in red blood cells from normal individuals and sickle cell patients. Cell Calcium 2012;51:51-6.
44. Zappulla D. Environmental stress, erythrocyte dysfunctions, inflammation, and the metabolic syndrome: adaptations to CO2 increases? J Cardiometab Syndr 2008;3:30-4.
45. Zbidah M, Lupescu A, Jilani K, Lang F. Stimulation of suicidal erythrocyte death by fumagillin. Basic Clin Pharmacol Toxicol 2013;112:346-51.
46. Zbidah M, Lupescu A, Shaik N, Lang F. Gossypol-induced suicidal erythrocyte death. Toxicology 2012;302:101-5.
47. Zelenak C, Pasham V, Jilani K, Tripodi PM, Rosaclerio L, Pathare G et al. Tanshinone IIA stimulates erythrocyte phosphatidylserine exposure. Cell Physiol Biochem 2012;30:282-94.
48. Abed M, Herrmann T, Alzoubi K, Pakladok T, Lang F. Tannic Acid induced suicidal erythrocyte death. Cell Physiol Biochem 2013;32:1106-16.
49. Ahmed MS, Langer H, Abed M, Voelkl J, Lang F. The uremic toxin acrolein promotes suicidal erythrocyte death. Kidney Blood Press Res 2013;37:158-67.
50. Ghashghaeinia M, Cluitmans JC, Toulany M, Saki M, Koberle M, Lang E et al. Age sensitivity of NFkappaB abundance and programmed cell death in erythrocytes induced by NFkappaB inhibitors. Cell Physiol Biochem 2013;32:801-13.
51. Abed M, Feger M, Alzoubi K, Pakladok T, Frauenfeld L, Geiger C et al. Sensitization of erythrocytes to suicidal erythrocyte death following water deprivation. Kidney Blood Press Res 2013;37:567-78.
52. Alzoubi K, Honisch S, Abed M, Lang F. Triggering of suicidal erythrocyte death by Penta-O-galloyl-beta-d-glucose. Toxins (Basel) 2014;6:54-65.
53. Jilani K, Lang F. Carmustine-induced phosphatidylserine translocation in the erythrocyte membrane. Toxins (Basel) 2013;5:703-16.
54. Jilani K, Enkel S, Bissinger R, Almilaji A, Abed M, Lang F. Fluoxetine induced suicidal erythrocyte death. Toxins (Basel) 2013;5:1230-43.
55. Lupescu A, Bissinger R, Jilani K, Lang F. Triggering of suicidal erythrocyte death by celecoxib. Toxins (Basel) 2013;5:1543-54.
56. Lupescu A, Jilani K, Zbidah M, Lang F. Patulin-induced suicidal erythrocyte death. Cell Physiol Biochem 2013;32:291-9.
57. Lang E, Qadri SM, Jilani K, Zelenak C, Lupescu A, Schleicher E et al. Carbon monoxide-sensitive apoptotic death of erythrocytes. Basic Clin Pharmacol Toxicol 2012;111:348-55.
58. Abed M, Zoubi KA, Theurer M, Lang F. Effect of dermaseptin on erythrocytes. Basic Clin Pharmacol Toxicol 2013;113:347-52.
59. Arnold M, Lang E, Modicano P, Bissinger R, Faggio C, Abed M et al. Effect of nitazoxanide on erythrocytes. Basic Clin Pharmacol Toxicol 2014;114:421-6.
60. Oswald G, Alzoubi K, Abed M, Lang F. Stimulation of suicidal erythrocyte death by ribavirin. Basic Clin Pharmacol Toxicol 2014;114:311-7.
61. Bissinger R, Malik A, Jilani K, Lang F. Triggering of erythrocyte cell membrane scrambling by salinomycin. Basic Clin Pharmacol Toxicol. doi:10.1111/bcpt.12250 [Epub ahead of print].
62. Zbidah M, Lupescu A, Herrmann T, Yang W, Foller M, Jilani K et al. Effect of honokiol on erythrocytes. Toxicol In Vitro 2013;27:1737-45.
63. Lupescu A, Jilani K, Zelenak C, Zbidah M, Shaik N, Lang F. Induction of programmed erythrocyte death by gambogic acid. Cell Physiol Biochem 2012;30:428-38.
64. Zbidah M, Lupescu A, Jilani K, Fajol A, Michael D, Qadri SM et al. Apigenin-induced suicidal erythrocyte death. J Agric Food Chem 2012;60:533-8.
65. Jilani K, Abed M, Zelenak C, Lang E, Qadri SM, Lang F. Triggering of erythrocyte cell membrane scrambling by ursolic acid. J Nat Prod 2011;74:2181-6.
66. Qadri SM, Mahmud H, Foller M, Lang F. Thymoquinone-induced suicidal erythrocyte death. Food Chem Toxicol 2009;47:1545-9.
67. Jilani K, Qadri SM, Zelenak C, Lang F. Stimulation of suicidal erythrocyte death by oridonin. Arch Biochem Biophys 2011;511:14-20.
68. Voelkl J, Alzoubi K, Mamar AK, Ahmed MS, Abed M, Lang F. Stimulation of suicidal erythrocyte death by increased extracellular phosphate concentrations. Kidney Blood Press Res 2013;38:42-51.
69. Kempe DS, Akel A, Lang PA, Hermle T, Biswas R, Muresanu J et al. Suicidal erythrocyte death in sepsis. J Mol Med 2007;85:269-77.
70. Foller M, Bobbala D, Koka S, Huber SM, Gulbins E, Lang F. Suicide for survival-death of infected erythrocytes as a host mechanism to survive malaria. Cell Physiol Biochem 2009;24:133-40.
71. Koka S, Lang C, Boini KM, Bobbala D, Huber SM, Lang F. Influence of chlorpromazine on eryptosis, parasitemia and survival of Plasmodium berghe infected mice. Cell Physiol Biochem 2008;22:261-8.
72. Koka S, Lang C, Niemoeller OM, Boini KM, Nicolay JP, Huber SM et al. Influence of NO synthase inhibitor L-NAME on parasitemia and survival of Plasmodium berghei infected mice. Cell Physiol Biochem 2008;21:481-8.
73. Totino PR, Daniel-Ribeiro CT, Ferreira-da-Cruz Mde F. Refractoriness of eryptotic red blood cells to Plasmodium falciparum infection: a putative host defense mechanism limiting parasitaemia. PLoS ONE 2011;6:e26575.
74. Lang KS, Roll B, Myssina S, Schittenhelm M, Scheel-Walter HG, Kanz L et al. Enhanced erythrocyte apoptosis in sickle cell anemia, thalassemia and glucose-6-phosphate dehydrogenase deficiency. Cell Physiol Biochem 2002;12:365-72.
75. Ayi K, Turrini F, Piga A, Arese P. Enhanced phagocytosis of ring-parasitized mutant erythrocytes: a common mechanism that may explain protection against falciparum malaria in sickle trait and beta-thalassemia trait. Blood 2004;104:3364-71.
76. de Jong K, Emerson RK, Butler J, Bastacky J, Mohandas N, Kuypers FA. Short survival of phosphatidylserine-exposing red blood cells in murine sickle cell anemia. Blood 2001;98:1577-84.
77. Kean LS, Brown LE, Nichols JW, Mohandas N, Archer DR, Hsu LL. Comparison of mechanisms of anemia in mice with sickle cell disease and beta-thalassemia: peripheral destruction, ineffective erythropoiesis, and phospholipid scramblase-mediated phosphatidylserine exposure. Exp Hematol 2002;30:394-402.
78. Browning JA, Robinson HC, Ellory JC, Gibson JS. Deoxygenation-induced non-electrolyte pathway in red cells from sickle cell patients. Cell Physiol Biochem 2007;19:165-74.
79. Chadebech P, Habibi A, Nzouakou R, Bachir D, Meunier-Costes N, Bonin P et al. Delayed hemolytic transfusion reaction in sickle cell disease patients: evidence of an emerging syndrome with suicidal red blood cell death. Transfusion 2009;49:1785-92.
80. Wood BL, Gibson DF, Tait JF. Increased erythrocyte phosphatidylserine exposure in sickle cell disease: flow-cytometric measurement and clinical associations. Blood 1996;88:1873-80.
81. Lang PA, Schenck M, Nicolay JP, Becker JU, Kempe DS, Lupescu A et al. Liver cell death and anemia in Wilson disease involve acid sphingomyelinase and ceramide. Nat Med 2007;13:164-70.
82. Kempe DS, Lang PA, Duranton C, Akel A, Lang KS, Huber SM et al. Enhanced programmed cell death of iron-deficient erythrocytes. FASEB J 2006;20:368-70.
83. Qadri SM, Mahmud H, Lang E, Gu S, Bobbala D, Zelenak C et al. Enhanced suicidal erythrocyte death in mice carrying a loss-of-function mutation of the adenomatous polyposis coli gene. J Cell Mol Med 2012;16:1085-93.
84. Myssina S, Huber SM, Birka C, Lang PA, Lang KS, Friedrich B et al. Inhibition of erythrocyte cation channels by erythropoietin. J Am Soc Nephrol 2003;14:2750-7.
85. Abed M, Artunc F, Alzoubi K, Honisch S, Baumann D, Foller M et al. Suicidal erythrocyte death in end-stage renal disease. J Mol Med (Berl) 2014;92:871-9. doi:10.1007/s00109-014-1151-4.
86. Lang PA, Beringer O, Nicolay JP, Amon O, Kempe DS, Hermle T et al. Suicidal death of erythrocytes in recurrent hemolytic uremic syndrome. J Mol Med 2006;84:378-88.
87. Birka C, Lang PA, Kempe DS, Hoefling L, Tanneur V, Duranton C et al. Enhanced susceptibility to erythrocyte "apoptosis" following phosphate depletion. Pflugers Arch 2004;448:471-7.
88. Kanematsu S, Uehara N, Miki H, Yoshizawa K, Kawanaka A, Yuri T et al. Autophagy inhibition enhances sulforaphane-induced apoptosis in human breast cancer cells. Anticancer Res 2010;30:3381-90.
89. Harrison HE, Bunting H, Ordway NK, Albrink WS. The pathogenesis of the renal injury produced in the dog by hemoglobin or methemoglobin. J Exp Med 1947;86:339-56.
90. Shieh P, Tsai ML, Chiu MH, Chen YO, Yi NL, Jan CR. Independent effects of the broccoli-derived compound sulforaphane on Ca2 + influx and apoptosis in Madin-Darby canine renal tubular cells. Chin J Physiol 2010;53:215-22.
91. Lang PA, Kempe DS, Myssina S, Tanneur V, Birka C, Laufer S et al. PGE(2) in the regulation of programmed erythrocyte death. Cell Death Differ 2005;12:415-28.
92. Duranton C, Huber S, Tanneur V, Lang K, Brand V, Sandu C et al. Electrophysiological properties of the Plasmodium Falciparum-induced cation conductance of human erythrocytes. Cell Physiol Biochem 2003;13:189-98.
93. Kirk K. Membrane transport in the malaria-infected erythrocyte. Physiol Rev 2001;81:495-537.
94. Ayi K, Giribaldi G, Skorokhod A, Schwarzer E, Prendergast PT, Arese P. 16alpha-bromoepiandrosterone, an antimalarial analogue of the hormone dehydroepiandrosterone, enhances phagocytosis of ring stage parasitized erythrocytes: a novel mechanism for antimalarial activity. Antimicrob Agents Chemother 2002;46:3180-4.
95. Cappadoro M, Giribaldi G, O'Brien E, Turrini F, Mannu F, Ulliers D et al. Early phagocytosis of glucose-6-phosphate dehydrogenase (G6PD)-deficient erythrocytes parasitized by Plasmodium falciparum may explain malaria protection in G6PD deficiency. Blood 1998;92:2527-34.
96. Koka S, Foller M, Lamprecht G, Boini KM, Lang C, Huber SM et al. Iron deficiency influences the course of malaria in Plasmodium berghei infected mice. Biochem Biophys Res Commun 2007;357:608-14.
97. Koka S, Huber SM, Boini KM, Lang C, Foller M, Lang F. Lead decreases parasitemia and enhances survival of Plasmodium berghei-infected mice. Biochem Biophys Res Commun 2007;363:484-9.
98. Borst O, Abed M, Alesutan I, Towhid ST, Qadri SM, Foller M et al. Dynamic adhesion of eryptotic erythrocytes to endothelial cells via CXCL16/SR-PSOX. Am J Physiol Cell Physiol 2012;302:C644-51.
99. Andrews DA, Low PS. Role of red blood cells in thrombosis. Curr Opin Hematol 1999;6:76-82.
100. Chung SM, Bae ON, Lim KM, Noh JY, Lee MY, Jung YS et al. Lysophosphatidic acid induces thrombogenic activity through phosphatidylserine exposure and procoagulant microvesicle generation in human erythrocytes. Arterioscler Thromb Vasc Biol 2007;27:414-21.
101. Zwaal RF, Comfurius P, Bevers EM. Surface exposure of phosphatidylserine in pathological cells. Cell Mol Life Sci 2005;62:971-88.
102. Closse C, Dachary-Prigent J, Boisseau MR. Phosphatidylserine-related adhesion of human erythrocytes to vascular endothelium. Br J Haematol 1999;107:300-2.
103. Gallagher PG, Chang SH, Rettig MP, Neely JE, Hillery CA, Smith BD et al. Altered erythrocyte endothelial adherence and membrane phospholipid asymmetry in hereditary hydrocytosis. Blood 2003;101:4625-7.
104. Pandolfi A, Di Pietro N, Sirolli V, Giardinelli A, Di Silvestre S, Amoroso L et al. Mechanisms of uremic erythrocyte-induced adhesion of human monocytes to cultured endothelial cells. J Cell Physiol 2007;213:699-709.